Sorbact dressings and bacteria and fungi from hard-to-heal wounds
Explores whether coated dressings bind germs from hard-to-heal wounds in adults.
Key facts
- Who runs it
- ABIGO Medical AB
- Where
- Sweden1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Clinical Investigation of Sorbact® Dressings
- Status
- Recruiting
- People taking part
- 30 people, planned
- Started
- 5 Apr 2025
- Expected to end
- Dec 2026
- Type of study
- Interventional, 3 groups
- Treatments tested
- Sorbact® Compress
- Sorbact® Gel Dressing
- Sorbact® Ribbon Gauze
- Record updated
- 14 September 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with a hard-to-heal wound who are about to start using a Sorbact® dressing. It studies how germs and fungi from the wound stick to the dressing.
- Age
- 18 years or older.
- Sex
- All sexes can join.
- Disease stage
- A hard-to-heal wound present for 6 weeks or more, with no clear shrinking of the wound in the last 4 weeks. This can be a diabetic foot ulcer, leg ulcer or pressure ulcer.
- Earlier treatment
- You must be due to start Sorbact® Compress, Sorbact® Gel Dressing or Sorbact® Ribbon Gauze. You cannot join if you used a germ-killing product (such as silver or iodine dressings or gels) or any Sorbact® dressing in the last two weeks.
Main reasons for not taking part
- Taking part in another clinical study.
- Known allergy or sensitivity to any part of the dressing used.
- Use of germ-killing dressings or gels in the last two weeks.
- Use of a Sorbact® dressing in the last two weeks.
- Any other condition that the study doctor thinks makes the study steps unsafe or unsuitable for you.
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Able to read and understand the Subject Information and Informed Consent Form and provide meaningful informed consent
- Due to start using one of the following dressings: Sorbact® Compress, Sorbact® Gel Dressing and Sorbact® Ribbon Gauze
- Age ≥18 years
- Presence of hard-to-heal wound for ≥6 weeks with no significant wound area reduction for the last 4 weeks confirmed by investigator/study nurse
Who cannot take part
- Known allergy or sensitivity to any components of the allocated investigational device
- Subjects with any other condition that as judged by the investigator may make investigation procedures inappropriate
- Participating in another clinical investigation
- Use of antimicrobial agent (e.g., silver- or iodine-containing dressings, or gels) during the last wo weeks
- Use of a dressing from the Sorbact® range during the last two weeks
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The main purpose of this exploratory clinical investigation is to study the binding of bacteria and fungi from hard-to-heal wounds to the DACC-coated dressings.
The 3 groups in the trial
- Sorbact® CompressOther group
Patients already assigned to start treatment with Sorbact® Compress as it is judged by the investigator to be the most suitable for their wounds
- Sorbact® Gel DressingOther group
Patients already assigned to start treatment with Sorbact® Gel Dressing as it is judged by the investigator to be the most suitable for their wounds
- Sorbact® Ribbon GauzeOther group
Patients already assigned to start treatment with Sorbact® Ribbon Gauze as it is judged by the investigator to be the most suitable for their wounds
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- An Open, Single-centre, Clinical Investigation to Explore the Binding of Bacteria and Fungi to Dialkylcarbamoyl Chloride (DACC)-Coated Dressings From Hard-to-heal Wounds
- Plain-language title
- Sorbact dressings and bacteria and fungi from hard-to-heal woundsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Record updated
- 14 September 2026